Prosecution Insights
Last updated: November 12, 2026

Psomri Holding AB

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Psomri Holding AB is managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active case is handled by 1 distinct examiner, YOO, SUN JAE, and is located in 1 distinct art unit. The busiest examiner for the portfolio is YOO, SUN JAE, who is responsible for 1 busiest examiner pending action. The portfolio's prosecution is currently concentrated under a single examiner and a single art unit.

For Psomri Holding AB, this indicates a very specific technical focus within the Biotechnology & Pharmaceuticals sector. The total of 1 pending office action matches the workload of the busiest examiner, YOO, SUN JAE, confirming that there is no distribution of pending cases across other examiners. This centralized structure suggests a direct prosecution path where the progress of the company's current patent efforts relies solely on the review and interpretation of a single examiner. While this simplifies the administrative burden, it also means that the company's immediate patent goals are tied to the specific examination style and technical standards of YOO, SUN JAE within a single art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YOO, SUN JAE 1 70.9% +1.0%

Top Art Units

Art UnitApps
1621 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18700978 NEW SALT FORMS OF AMILORIDE AND ITS DERIVATIVES FOR PHARMACEUTICAL USE YOO, SUN JAE 1621 §103 Non-Final OA — Pending Apr 12, 2024

Managing Psomri Holding AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Psomri Holding AB have?

Psomri Holding AB has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Psomri Holding AB applications?

Sun Jae Yoo has the most, with 1 of Psomri Holding AB's pending office actions.

What technology area are Psomri Holding AB's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month